Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
D06BB Antivirals
D06BB07 Lysozyme
D08152 Lysozyme (DCF)
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX02 Lysozyme
D08152 Lysozyme (DCF)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07A INTESTINAL ANTIINFECTIVES
A07AA Antibiotics
A07AA05 Polymyxin B
D08401 Polymyxin B (INN)
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01X OTHER ANTIBACTERIALS
J01XB Polymyxins
J01XB02 Polymyxin B
D08401 Polymyxin B (INN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AA Antibiotics
S01AA18 Polymyxin B
D08401 Polymyxin B (INN)
S02 OTOLOGICALS
S02A ANTIINFECTIVES
S02AA Antiinfectives
S02AA11 Polymyxin B
D08401 Polymyxin B (INN)
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S03A ANTIINFECTIVES
S03AA Antiinfectives
S03AA03 Polymyxin B
D08401 Polymyxin B (INN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Polymyxin B
D08401 Polymyxin B (INN)
Drug groups [BR:br08330]
Antibacterial
DG01579 Polypeptide antibiotic
DG00083 Polymyxin B
D08401 Polymyxin B
Antimicrobials [BR:br08307]
Antibacterials
Cell membrane function inhibitor
Polypeptide
D08401 Polymyxin B (INN)
Drug groups [BR:br08330]
Antibacterial
DG01579 Polypeptide antibiotic
DG00083 Polymyxin B
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell membrane function inhibitor
Polypeptide
DG00083 Polymyxin B
Natural product
Glycopeptide
Vancomycin makes complex formation with D-alanyl-D-alanine of Peptidoglycan, and inhibites cross-link between protein and peptideglycan.